Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomic polymorphisms in sepsis.

Mark T Lin1, Timothy E Albertson

  • 1Division of Pulmonary and Critical Care Medicine, University of California, San Diego, CA, USA.

Critical Care Medicine
|February 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transient Neonatal Cyanosis Exacerbated by Inhaled Nitric Oxide.

AJP reports·2026
Same author

Pediatric Intravenous Acetaminophen Overdoses: A Continuing Iatrogenic Problem.

Hospital pediatrics·2026
Same author

Biological sex modulates lung injury severity in adolescent mice exposed to short-term aerosolized vitamin E acetate.

Physiological reports·2025
Same author

Unmasking the Hidden Risk of Systemic Toxicity from Topical Salicylates.

The western journal of emergency medicine·2025
Same author

Single-Agent Divarasib in Patients With <i>KRAS G12C</i>-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

A ten-year retrospective California Poison Control System experience with water bead exposures: a growing problem.

Clinical toxicology (Philadelphia, Pa.)·2025
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Attracting Emergency Medicine Graduates to Surgical Critical Care Training Programs.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Beyond a Snapshot: Tracking Family Prognostic Expectations in the ICU.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure: Beware of Potential Confounders.

Critical care medicine·2026
See all related articles

Genetic variations influence sepsis risk and severity. Studies show links between specific genetic polymorphisms and increased sepsis susceptibility or mortality, warranting further investigation into these innate immunity and inflammation pathways.

Area of Science:

  • Genetics
  • Immunology
  • Pathogenesis of Infectious Diseases

Background:

  • Sepsis remains a leading cause of mortality despite advances in treatment.
  • Genetic factors are increasingly recognized for their role in sepsis susceptibility and outcomes.
  • Understanding genetic polymorphisms offers potential for personalized medicine in sepsis management.

Purpose of the Study:

  • To review genetic polymorphism studies related to sepsis pathogenesis.
  • To focus on polymorphisms in innate immunity, cytokines, and coagulation mediators.
  • To assess the contribution of genetic variants to sepsis development and severity.

Main Methods:

  • Systematic review of published genetic polymorphism studies.
  • Inclusion of studies on sepsis, septic shock, and infectious disease models.

Related Experiment Videos

  • Analysis of associations between genetic variants and sepsis-related outcomes.

    • Main Results:

    • Identified intriguing associations between certain genetic polymorphisms and increased sepsis mortality or susceptibility.
    • Highlighted the role of innate immunity, pro- and anti-inflammatory cytokine, and coagulation mediator polymorphisms.
    • Acknowledged limitations due to small, heterogeneous study populations.

    Conclusions:

    • Genetic polymorphisms show potential as biomarkers for sepsis risk and severity.
    • Further research is needed to establish causal relationships and explore genetic and molecular mechanisms.
    • Genomic information may guide future therapeutic strategies and outcome prediction in sepsis.